Adverse Event reporting can be found below.
Our Portfolio
We provide high-quality and cost–effective respiratory medicines for sustainable NHS care. Visit our Respiratory Hub.
Proxor® (beclometasone/formoterol)
Proxor® is a beclometasone/formoterol pressurised metered-dose inhaler (pMDI) which is therapeutically equivalent to Fostair® pMDI, with cost-savings of up to 66%.3,4
Prescribing information is available here.
Fixkoh® (salmeterol/fluticasone)
Fixkoh Airmaster is a salmeterol/fluticasone dry powder inhaler (DPI) which is therapeutically equivalent to Seretide® Accuhaler®, with cost-savings of up to 51%5,6
Prescribing information is available here.
Trokide® (tiotropium bromide)
Trokide Vertical-Haler® is a dry powder inhaler (DPI) which is therapeutically equivalent to Spiriva® Handihaler,® with cost-savings of up to 71%.1,2
Prescribing information is available here.
Information
For SmPC follow the links which will take you to the Electronic Medicines Compendium (emc) website which is a non-Thornton & Ross website. https://www.medicines.org.uk/emc/.
References: 1. STADA UK Ltd. 2024. Data on File. Trokide Pharmaceutical Development. 2. STADA UK Ltd. 2024. Data on File. Based on indicative NHS list prices and IQVIA data. 3. STADA UK Ltd. 2024. Data on File. Proxor Pharmaceutical Development. 4. STADA UK Ltd. 2024. Data on File. Based on indicative NHS list prices and IQVIA data. 5. STADA UK Ltd. 2024. Data on File. Fixkoh Pharmaceutical Development. 6. STADA UK Ltd. 2024. Data on File. Based on indicative NHS list prices and IQVIA data.
Adverse events should be reported. Reporting forms and information can be found at yellowcard.mhra.gov.uk or search for MHRA Yellow Card in the Google Play or Apple App Store. Adverse events should also be reported to Thornton and Ross Limited by emailing [email protected] or by calling 01484 848164.
UK-MULT-321(1) | March 2026
